Nomura Holdings Inc Esperion Therapeutics, Inc. Transaction History

Nomura Holdings Inc

$41.1 Billion
Q3 2024

A detailed history of Nomura Holdings Inc transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Nomura Holdings Inc holds 23,578 shares of ESPR stock, worth $59,416. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,578

Previous 23,578 -0.0%

Holding current value

$59,416

Previous $52,000 26.92%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.02 - $3.02 $47,627 - $71,205	23,578 New	23,578 $63,000
Q4 2023 Feb 14, 2024	SELL	$0.73 - $3.08 $57,433 - $242,322	-78,676 Reduced 67.81%	37,345 $111,000
Q1 2023 May 15, 2023	SELL	$1.46 - $7.3 $106,985 - $534,929	-73,278 Reduced 38.71%	116,021 $184,000
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $963,531 - $1.61 Million	189,299 New	189,299 $1.17 Million
Q4 2021 Feb 14, 2022	SELL	$4.81 - $11.92 $149,326 - $370,056	-31,045 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$11.34 - $21.37 $652,764 - $1.23 Million	-57,563 Reduced 64.96%	31,045 $369,000
Q2 2021 Aug 16, 2021	BUY	$19.4 - $28.71 $331,371 - $490,395	17,081 Added 23.88%	88,608 $1.88 Million
Q1 2021 May 17, 2021	SELL	$25.12 - $36.89 $5.46 Million - $8.02 Million	-217,291 Reduced 75.23%	71,527 $2 Million
Q4 2020 Feb 16, 2021	BUY	$24.2 - $35.76 $1.54 Million - $2.28 Million	63,818 Added 28.36%	288,818 $7.53 Million
Q1 2020 May 14, 2020	SELL	$27.44 - $73.84 $8.92 Million - $24 Million	-325,000 Reduced 59.09%	225,000 $7.08 Million
Q1 2019 May 14, 2019	BUY	$40.11 - $53.57 $3.42 Million - $4.57 Million	85,300 Added 18.36%	550,000 $22 Million
Q4 2018 Feb 14, 2019	BUY	$36.99 - $59.11 $6.83 Million - $10.9 Million	184,700 Added 65.96%	464,700 $21.3 Million
Q3 2018 Nov 14, 2018	BUY	$40.74 - $51.41 $1.22 Million - $1.54 Million	30,000 Added 12.0%	280,000 $12.7 Million
Q2 2018 Aug 14, 2018	BUY	$36.2 - $76.4 $8.87 Million - $18.7 Million	245,000 Added 4900.0%	250,000 $9.15 Million
Q1 2018 May 14, 2018	BUY	$65.94 - $80.76 $329,700 - $403,800	5,000 New	5,000 $362,000

Others Institutions Holding ESPR

# of Institutions

207

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $168M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Account

Nomura Holdings Inc Esperion Therapeutics, Inc. Transaction History